182 related articles for article (PubMed ID: 34504197)
1. RAS specific protease induces irreversible growth arrest via p27 in several KRAS mutant colorectal cancer cell lines.
Stubbs CK; Biancucci M; Vidimar V; Satchell KJF
Sci Rep; 2021 Sep; 11(1):17925. PubMed ID: 34504197
[TBL] [Abstract][Full Text] [Related]
2. The bacterial Ras/Rap1 site-specific endopeptidase RRSP cleaves Ras through an atypical mechanism to disrupt Ras-ERK signaling.
Biancucci M; Minasov G; Banerjee A; Herrera A; Woida PJ; Kieffer MB; Bindu L; Abreu-Blanco M; Anderson WF; Gaponenko V; Stephen AG; Holderfield M; Satchell KJF
Sci Signal; 2018 Oct; 11(550):. PubMed ID: 30279169
[TBL] [Abstract][Full Text] [Related]
3. Structural basis of inactivation of Ras and Rap1 small GTPases by Ras/Rap1-specific endopeptidase from the sepsis-causing pathogen
Jang SY; Hwang J; Kim BS; Lee EY; Oh BH; Kim MH
J Biol Chem; 2018 Nov; 293(47):18110-18122. PubMed ID: 30282804
[TBL] [Abstract][Full Text] [Related]
4. Proteolytic pan-RAS Cleavage Leads to Tumor Regression in Patient-derived Pancreatic Cancer Xenografts.
Vidimar V; Park M; Stubbs CK; Ingram NK; Qiang W; Zhang S; Gursel D; Melnyk RA; Satchell KJF
Mol Cancer Ther; 2022 May; 21(5):810-820. PubMed ID: 35247912
[TBL] [Abstract][Full Text] [Related]
5. Non-Redundant and Overlapping Oncogenic Readouts of Non-Canonical and Novel Colorectal Cancer KRAS and NRAS Mutants.
Alcantara KMM; Malapit JRP; Yu RTD; Garrido JAMG; Rigor JPT; Angeles AKJ; Cutiongco-de la Paz EM; Garcia RL
Cells; 2019 Dec; 8(12):. PubMed ID: 31816869
[TBL] [Abstract][Full Text] [Related]
6. 4-Acetyl-Antroquinonol B Improves the Sensitization of Cetuximab on Both Kras Mutant and Wild Type Colorectal Cancer by Modulating the Expression of Ras/Raf/miR-193a-3p Signaling Axis.
Chu YC; Tsai TY; Yadav VK; Deng L; Huang CC; Tzeng YM; Yeh CT; Chen MY
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299137
[TBL] [Abstract][Full Text] [Related]
7. Substrate Recognition of MARTX Ras/Rap1-Specific Endopeptidase.
Biancucci M; Rabideau AE; Lu Z; Loftis AR; Pentelute BL; Satchell KJF
Biochemistry; 2017 May; 56(21):2747-2757. PubMed ID: 28459538
[TBL] [Abstract][Full Text] [Related]
8. A systems mechanism for KRAS mutant allele-specific responses to targeted therapy.
McFall T; Diedrich JK; Mengistu M; Littlechild SL; Paskvan KV; Sisk-Hackworth L; Moresco JJ; Shaw AS; Stites EC
Sci Signal; 2019 Sep; 12(600):. PubMed ID: 31551296
[TBL] [Abstract][Full Text] [Related]
9. Metabonomics study of the effects of single copy mutant KRAS in the presence or absence of WT allele using human HCT116 isogenic cell lines.
Varshavi D; Varshavi D; McCarthy N; Veselkov K; Keun HC; Everett JR
Metabolomics; 2021 Nov; 17(12):104. PubMed ID: 34822010
[TBL] [Abstract][Full Text] [Related]
10. Isoform-Specific Destabilization of the Active Site Reveals a Molecular Mechanism of Intrinsic Activation of KRas G13D.
Johnson CW; Lin YJ; Reid D; Parker J; Pavlopoulos S; Dischinger P; Graveel C; Aguirre AJ; Steensma M; Haigis KM; Mattos C
Cell Rep; 2019 Aug; 28(6):1538-1550.e7. PubMed ID: 31390567
[TBL] [Abstract][Full Text] [Related]
11. PDEδ inhibition impedes the proliferation and survival of human colorectal cancer cell lines harboring oncogenic KRas.
Klein CH; Truxius DC; Vogel HA; Harizanova J; Murarka S; Martín-Gago P; Bastiaens PIH
Int J Cancer; 2019 Feb; 144(4):767-776. PubMed ID: 30194764
[TBL] [Abstract][Full Text] [Related]
12. Synthetic Lethality of a Novel Small Molecule Against Mutant KRAS-Expressing Cancer Cells Involves AKT-Dependent ROS Production.
Iskandar K; Rezlan M; Yadav SK; Foo CH; Sethi G; Qiang Y; Bellot GL; Pervaiz S
Antioxid Redox Signal; 2016 May; 24(14):781-94. PubMed ID: 26714745
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic RAS isoforms show a hierarchical requirement for the guanine nucleotide exchange factor SOS2 to mediate cell transformation.
Sheffels E; Sealover NE; Wang C; Kim DH; Vazirani IA; Lee E; M Terrell E; Morrison DK; Luo J; Kortum RL
Sci Signal; 2018 Sep; 11(546):. PubMed ID: 30181243
[TBL] [Abstract][Full Text] [Related]
14. An engineered chimeric toxin that cleaves activated mutant and wild-type RAS inhibits tumor growth.
Vidimar V; Beilhartz GL; Park M; Biancucci M; Kieffer MB; Gius DR; Melnyk RA; Satchell KJF
Proc Natl Acad Sci U S A; 2020 Jul; 117(29):16938-16948. PubMed ID: 32616570
[TBL] [Abstract][Full Text] [Related]
15. MAP kinase and autophagy pathways cooperate to maintain RAS mutant cancer cell survival.
Lee CS; Lee LC; Yuan TL; Chakka S; Fellmann C; Lowe SW; Caplen NJ; McCormick F; Luo J
Proc Natl Acad Sci U S A; 2019 Mar; 116(10):4508-4517. PubMed ID: 30709910
[TBL] [Abstract][Full Text] [Related]
16. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
[TBL] [Abstract][Full Text] [Related]
17. Adrenomedullin is a therapeutic target in colorectal cancer.
Wang L; Gala M; Yamamoto M; Pino MS; Kikuchi H; Shue DS; Shirasawa S; Austin TR; Lynch MP; Rueda BR; Zukerberg LR; Chung DC
Int J Cancer; 2014 May; 134(9):2041-50. PubMed ID: 24519534
[TBL] [Abstract][Full Text] [Related]
18. Specific inhibition of p110α subunit of PI3K: putative therapeutic strategy for KRAS mutant colorectal cancers.
Fernandes MS; Melo S; Velho S; Carneiro P; Carneiro F; Seruca R
Oncotarget; 2016 Oct; 7(42):68546-68558. PubMed ID: 27602501
[TBL] [Abstract][Full Text] [Related]
19. Absolute Quantification of Endogenous Ras Isoform Abundance.
Mageean CJ; Griffiths JR; Smith DL; Clague MJ; Prior IA
PLoS One; 2015; 10(11):e0142674. PubMed ID: 26560143
[TBL] [Abstract][Full Text] [Related]
20. Reduced HRAS G12V-Driven Tumorigenesis of Cell Lines Expressing KRAS C118S.
Huang L; Counter CM
PLoS One; 2015; 10(4):e0123918. PubMed ID: 25902334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
